Search Results - ovcar-8

1 Results

Sort By:

Adriamycin-Resistant Ovarian Tumor Cell Line, NCI/ADR-RES

Summary: NCI is seeking parties to non-exclusively license the ADR-RES cell line. Description of Technology: Cancer cells may acquire drug resistance after prolonged chemotherapy. In many cases, cancer cells develop resistance to several drugs with distinct structures and modes of action. This multi-drug resistance phenomenon increases the complexity...

Published: 4/24/2026 | Updated: 8/2/2023 | Inventor(s): Kenneth Cowan

Keywords(s): ADENOCARCINOMA, Adriamycin-resistant, Cell line, Cowan, MCF-7/ADR-RES, MDR1, Multi-Drug Resistance, NCI/ADR-RES, OVARIAN CANCER, OVCAR-8, P-GLYCOPROTEIN

Category(s): Collaboration Sought > Licensing, Application > Research Materials, TherapeuticArea > Oncology